Welcome to the latest episode of our podcast, where we discuss the latest breakthrough in the fight against Alzheimer's disease. In today's episode, we discussed the new monoclonal antibidy, Donanemab, that is offering hope to Alzheimer's patients and their families, and how Donanemab is different from other treatments. Donanemab is a monoclonal antibody that has shown promising results in clinical trials. It works by targeting a protein called amyloid-beta, which is believed to play a significant role in the development of Alzheimer's disease. The drug binds to the amyloid-beta protein and clears it from the brain, reducing the amount of plaque buildup that causes damage to brain cells. While the results of the clinical trials are promising, there are still many challenges to overcome. Donanemab is expensive and requires regular infusions, which may limit its accessibility. There is also a need for further research to determine the long-term effects of the drug and its efficacy in treating different stages of Alzheimer's. Follow us: Join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com  

This episode is a conversation with the New York Times bestselling author and neuroscientist, Lisa Genova. Her debut novel Still Alice about a Harvard University professor who suffers early onset Alzheimer's disease sold millions of copies and has been translated into 37 languages. The book was adapted into a film in 2014 and won the Academy Award for Best Actress for Julianne Moore's highly acclaimed performance as Alice Howland. Her first work of nonfiction, REMEMBER: The Science of Memory and the Art of Forgetting, was published in March 2021, and was an instant New York Times bestseller. Her first TED talk, "What You Can Do To Prevent Alzheimer's" has been viewed over eight million times and her most recent TED talk, "How Memory Works--and Why Forgetting is Totally OK" was the sixth most watched TED talk of 2021. She has been recognized numerous times and has won many awards for here incredible work, including receiving The Pell Center Prize for Story in the Public Square, for "distinguished storytelling that has enriched the public dialogue."  We discussed her journey of becoming a story teller, her empowering message and important work for the community.  Follow Lisa: Instagram: @authorlisagenova Twitter: @lisagenova Website: LisaGenova.com   Follow us: Join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com  

This episode is a deep dive into the topic of headache with our colleague, an expert in the field of headache medicine, Dr. Chelsea Stone. We explored the definition, classification, general presentation, diagnosis and some of the latest treatments available for headaches.  Dr. Stone is a board-certified neurologist with specialty in Headache Medicine. She holds a master’s degree in psychology, completed her neurology residency at Loma Linda University Medical Center and fellowship in headache medicine at University of Soutern California, where she now serves as full time faculty. Dr. Stone understands the unique challenges of chronic pain and takes a collaborative and multidisciplinary approach to patient care, with special interest in treating pregnant and lactating women. In addition to patient care, Dr. Stone is very passionate about physician well-being and serves as Assistant Program Director of Wellness for the neurology residency program at LA County + USC and as the Well-being Champion for the Keck neurology department. Follow us: To participate in the weekly NEURO Science Club and join the discussions about the latest on brain health, join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com      

In this episode, we discuss epilepsy and describe the life of the 19th century philosopher and writer, Fyodor Dostoevsky, and how the seizures that tormented him throughout his life would become both a source of creative inspiration and an obstacle that he struggled to overcome. You can read the blog by visiting our website here. Follow us: Join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com

In this episode, we explore Parkinson's disease (PD), which is the second most common neurodegenerative disorder of aging after Alzheimer's disease, and the most common movement disorder. It affects approximately 1 million people in the United States, and it is estimated that 60,000 new cases are diagnosed each year. Worldwide more than 10 million people suffer from PD.  We described the disease in a patient story, discussed its epidemiology, causal pathways including genetics, signs and symptoms, medical and invasive treatments, prevention and future trends in research.  For more reading, here are some references:  Bloem, Bastiaan R., Michael S. Okun, and Christine Klein. "Parkinson's disease." The Lancet 397.10291 (2021): 2284-2303. Ascherio, Alberto, and Michael A. Schwarzschild. "The epidemiology of Parkinson's disease: risk factors and prevention." The Lancet Neurology 15.12 (2016): 1257-1272. Chen, Honglei, et al. "Consumption of dairy products and risk of Parkinson's disease." American journal of epidemiology, 165.9 (2007): 998-1006. Warnecke, Tobias, et al. "Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management." npj Parkinson's Disease 8.1 (2022): 31. Follow us: To participate in the weekly NEURO Science Club and join the discussions about the latest on brain health, join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com